MSH2 and colorectal carcinoma: The study found that carriers of an EPCAM deletion had a 75% cumulative risk of developing CRC before the age of 70, similar to that of carriers of combined EPCAM-MSH2 deletions or MSH2 mutations, but higher than that observed in MSH6 mutation carriers.